Ipilimumab alone or in combination with radiotherapy in metastatic castration-resistant prostate cancer: results from an open-label, multicenter phase I/II study
書誌事項
- 公開日
- 2013-07
- 権利情報
-
- https://www.elsevier.com/tdm/userlicense/1.0/
- http://www.elsevier.com/open-access/userlicense/1.0/
- DOI
-
- 10.1093/annonc/mdt107
- 公開者
- Elsevier BV
この論文をさがす
収録刊行物
-
- Annals of Oncology
-
Annals of Oncology 24 (7), 1813-1821, 2013-07
Elsevier BV